Japan Tissue Engineering Co., Ltd. (7774.T)
JPY 630.0
(-0.16%)
JPY 630.0
(-0.16%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 6.98 Billion JPY | 1.53% |
| 2022 | 6.88 Billion JPY | -9.41% |
| 2021 | 7.59 Billion JPY | -6.42% |
| 2020 | 8.11 Billion JPY | -3.93% |
| 2019 | 8.45 Billion JPY | -3.43% |
| 2018 | 8.75 Billion JPY | -3.0% |
| 2017 | 9.02 Billion JPY | 5.58% |
| 2016 | 8.54 Billion JPY | 3.01% |
| 2015 | 8.29 Billion JPY | -6.29% |
| 2014 | 8.85 Billion JPY | 173.87% |
| 2013 | 3.23 Billion JPY | 0.73% |
| 2012 | 3.2 Billion JPY | -28.6% |
| 2011 | 4.49 Billion JPY | -22.93% |
| 2010 | 5.83 Billion JPY | 82.37% |
| 2009 | 3.19 Billion JPY | -7.4% |
| 2008 | 3.45 Billion JPY | -20.2% |
| 2007 | 4.32 Billion JPY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 6.63 Billion JPY | -5.13% |
| 2024 Q2 | 6.48 Billion JPY | -2.16% |
| 2023 Q1 | 6.9 Billion JPY | 0.26% |
| 2023 Q3 | 6.86 Billion JPY | 1.25% |
| 2023 FY | 6.98 Billion JPY | 1.53% |
| 2023 Q2 | 6.77 Billion JPY | -1.81% |
| 2023 Q4 | 6.98 Billion JPY | 1.86% |
| 2022 Q4 | 6.88 Billion JPY | -0.5% |
| 2022 Q3 | 6.91 Billion JPY | -2.9% |
| 2022 Q2 | 7.12 Billion JPY | -3.03% |
| 2022 Q1 | 7.34 Billion JPY | -3.31% |
| 2022 FY | 6.88 Billion JPY | -9.41% |
| 2021 Q4 | 7.59 Billion JPY | -0.03% |
| 2021 Q3 | 7.6 Billion JPY | -1.85% |
| 2021 Q2 | 7.74 Billion JPY | -1.95% |
| 2021 Q1 | 7.89 Billion JPY | -2.73% |
| 2021 FY | 7.59 Billion JPY | -6.42% |
| 2020 FY | 8.11 Billion JPY | -3.93% |
| 2020 Q2 | 8.15 Billion JPY | -1.37% |
| 2020 Q3 | 7.98 Billion JPY | -2.18% |
| 2020 Q4 | 8.11 Billion JPY | 1.73% |
| 2020 Q1 | 8.27 Billion JPY | -2.12% |
| 2019 Q1 | 8.44 Billion JPY | -3.45% |
| 2019 Q2 | 8.26 Billion JPY | -2.14% |
| 2019 Q3 | 8.22 Billion JPY | -0.48% |
| 2019 FY | 8.45 Billion JPY | -3.43% |
| 2019 Q4 | 8.45 Billion JPY | 2.7% |
| 2018 FY | 8.75 Billion JPY | -3.0% |
| 2018 Q2 | 8.52 Billion JPY | -2.52% |
| 2018 Q1 | 8.74 Billion JPY | -3.07% |
| 2018 Q3 | 8.5 Billion JPY | -0.27% |
| 2018 Q4 | 8.75 Billion JPY | 2.92% |
| 2017 Q4 | 9.02 Billion JPY | 3.61% |
| 2017 FY | 9.02 Billion JPY | 5.58% |
| 2017 Q3 | 8.7 Billion JPY | 0.52% |
| 2017 Q2 | 8.66 Billion JPY | 0.92% |
| 2017 Q1 | 8.58 Billion JPY | 0.45% |
| 2016 FY | 8.54 Billion JPY | 3.01% |
| 2016 Q2 | 8.07 Billion JPY | -1.08% |
| 2016 Q3 | 8.14 Billion JPY | 0.93% |
| 2016 Q4 | 8.54 Billion JPY | 4.87% |
| 2016 Q1 | 8.16 Billion JPY | -1.62% |
| 2015 Q1 | 8.67 Billion JPY | -2.06% |
| 2015 FY | 8.29 Billion JPY | -6.29% |
| 2015 Q4 | 8.29 Billion JPY | 0.53% |
| 2015 Q3 | 8.25 Billion JPY | -2.72% |
| 2015 Q2 | 8.48 Billion JPY | -2.16% |
| 2014 Q3 | 9.58 Billion JPY | 234.06% |
| 2014 Q2 | 2.86 Billion JPY | -4.9% |
| 2014 FY | 8.85 Billion JPY | 173.87% |
| 2014 Q1 | 3.01 Billion JPY | -6.71% |
| 2014 Q4 | 8.85 Billion JPY | -7.59% |
| 2013 Q3 | 2.7 Billion JPY | -9.14% |
| 2013 FY | 3.23 Billion JPY | 0.73% |
| 2013 Q2 | 2.97 Billion JPY | -2.51% |
| 2013 Q4 | 3.23 Billion JPY | 19.65% |
| 2013 Q1 | 3.05 Billion JPY | -4.96% |
| 2012 Q2 | 3.82 Billion JPY | -8.25% |
| 2012 Q1 | 4.17 Billion JPY | -7.21% |
| 2012 Q3 | 3.51 Billion JPY | -8.23% |
| 2012 Q4 | 3.2 Billion JPY | -8.6% |
| 2012 FY | 3.2 Billion JPY | -28.6% |
| 2011 Q2 | 5.15 Billion JPY | -6.91% |
| 2011 Q3 | 4.81 Billion JPY | -6.54% |
| 2011 Q4 | 4.49 Billion JPY | -6.74% |
| 2011 FY | 4.49 Billion JPY | -22.93% |
| 2011 Q1 | 5.53 Billion JPY | -5.02% |
| 2010 Q2 | 2.83 Billion JPY | -11.07% |
| 2010 FY | 5.83 Billion JPY | 82.37% |
| 2010 Q3 | 6.2 Billion JPY | 118.52% |
| 2010 Q4 | 5.83 Billion JPY | -6.03% |
| 2010 Q1 | 3.19 Billion JPY | -0.13% |
| 2009 Q4 | 3.19 Billion JPY | -0.05% |
| 2009 Q2 | 3.45 Billion JPY | -5.72% |
| 2009 Q1 | 3.66 Billion JPY | 6.09% |
| 2009 Q3 | 3.19 Billion JPY | -7.37% |
| 2009 FY | 3.19 Billion JPY | -7.4% |
| 2008 Q4 | 3.45 Billion JPY | 1.25% |
| 2008 FY | 3.45 Billion JPY | -20.2% |
| 2008 Q3 | 3.41 Billion JPY | 0.0% |
| 2007 FY | 4.32 Billion JPY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 6.58 Billion JPY | -6.062% |
| PRISM BioLab Co.,LTD | 1.21 Billion JPY | -476.905% |
| GNI Group Ltd. | 62.39 Billion JPY | 88.799% |
| Linical Co., Ltd. | 18.53 Billion JPY | 62.304% |
| Trans Genic Inc. | 9.81 Billion JPY | 28.766% |
| MEDINET Co., Ltd. | 5.63 Billion JPY | -24.043% |
| Soiken Holdings Inc. | 6.94 Billion JPY | -0.614% |
| Cytori Cell Research Institute, Inc. | 5.81 Billion JPY | -20.158% |
| AnGes, Inc. | 28.89 Billion JPY | 75.811% |
| OncoTherapy Science, Inc. | 867.27 Million JPY | -705.831% |
| Nxera Pharma Co., Ltd. | 157.19 Billion JPY | 95.554% |
| Immuno-Biological Laboratories Co., Ltd. | 1.61 Billion JPY | -331.784% |
| NanoCarrier Co., Ltd. | 5.07 Billion JPY | -37.811% |
| Carna Biosciences, Inc. | 4.34 Billion JPY | -60.665% |
| CanBas Co., Ltd. | 2.43 Billion JPY | -187.266% |
| D. Western Therapeutics Institute, Inc. | 2.37 Billion JPY | -194.466% |
| RaQualia Pharma Inc. | 6.93 Billion JPY | -0.844% |
| Chiome Bioscience Inc. | 1.75 Billion JPY | -299.027% |
| Kidswell Bio Corporation | 5.08 Billion JPY | -37.424% |
| PeptiDream Inc. | 67.12 Billion JPY | 89.589% |
| Oncolys BioPharma Inc. | 2.04 Billion JPY | -242.487% |
| Ribomic Inc. | 3.54 Billion JPY | -97.019% |
| SanBio Company Limited | 5.04 Billion JPY | -38.466% |
| Healios K.K. | 15.15 Billion JPY | 53.885% |
| BrightPath Biotherapeutics Co., Ltd. | 1.23 Billion JPY | -468.074% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 3.01 Billion JPY | -131.723% |
| Delta-Fly Pharma, Inc. | 1.47 Billion JPY | -374.087% |
| StemRIM | 9.08 Billion JPY | 23.031% |
| CellSource Co., Ltd. | 6.87 Billion JPY | -1.585% |
| FunPep Company Limited | 2.49 Billion JPY | -180.546% |
| Kringle Pharma, Inc. | 2.61 Billion JPY | -166.884% |
| Stella Pharma Corporation | 3.82 Billion JPY | -82.922% |
| TMS Co., Ltd. | 3.55 Billion JPY | -96.604% |
| Noile-Immune Biotech Inc. | 5.77 Billion JPY | -20.935% |
| Cuorips Inc. | 6.18 Billion JPY | -13.0% |
| K Pharma,Inc. | 3.31 Billion JPY | -110.893% |
| Takara Bio Inc. | 123.2 Billion JPY | 94.328% |
| ReproCELL Incorporated | 9.05 Billion JPY | 22.798% |
| PhoenixBio Co., Ltd. | 2.71 Billion JPY | -157.383% |
| StemCell Institute Inc. | 6.54 Billion JPY | -6.812% |
| CellSeed Inc. | 2.46 Billion JPY | -183.432% |